Imquest Biosciences, Inc.
Frederick, MD
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 7340 Executive Way, Frederick, MD 21704, USA
- Website
- imquestbio.com
- Founded
- 2004
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Govsmart, Inc. | 75N93024F00001 | $31,626 | |
| Camris International, LLC | 75N93024F00001 | $49,390 | |
| Govsmart, Inc. | 75N93024F00001 | $133,835 | |
| Professional And Scientific Associates, Inc. | 75N93023F00002 | $25,048 | |
| Gap Solutions, Inc. | 75N93023F00001 | $265,963 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Imquest Biosciences, Inc., doing business as Imquest Biosciences Inc., is a preclinical contract research and development organization that provides services to evaluate the potential of new and novel pharmaceutical products for the treatment and prevention of viruses, bacteria, cancer, and inflammation. It has been registered in SAM.gov since July 30, 2004, as a for-profit corporate entity.
Imquest Biosciences, Inc. has received two prime federal contract awards from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the Department of Health and Human Services. In 2022, they were awarded a $16,000 purchase order for "NIDDK - HIV CYTOPROTECTION ASSAYS 16 COMPOUNDS" with a completion date of August 31, 2023. Previously, in 2019, they received a $33,000 purchase order for "ANTI-HIV EVALUATION" which was completed in August 2020. Both awards were not set aside for any specific business categories. Additionally, Imquest Biosciences, Inc. has been awarded two sub-contract awards from Research Triangle Institute, but detailed descriptions of these sub-contracts are not provided.
SBA capabilities narrative
ImQuest BioSciences provides preclinical contract research and development services to help pharmaceutical and biotechnology companies successfully bring new pharmaceuticals and biologics to market. ImQuest BioSciences offers non-GLP and GLP compliant services to define the efficacy, safety, and pharmaceutical property of drug candidates and potential new biologics from initial discovery and screening to IND-enabling studies. ImQuest Biosciences provides expert professional and technical services. Our technical services include, flow cytometry, immunoassay development, molecular biology, tissue culture, virus production, enzymology, and analytical services to facilitate and streamline your laboratory operations and discovery initiatives.
Quick answers
Is Imquest Biosciences, Inc. registered in SAM.gov?
Yes. Imquest Biosciences, Inc.'s SAM.gov registration is active through January 27, 2027.
What is Imquest Biosciences, Inc.'s CAGE code?
Imquest Biosciences, Inc.'s CAGE code is 3Y2E4, and its Unique Entity ID (UEI) is Y7ETNZCNSLM5.
What is Imquest Biosciences, Inc.'s most recent federal award?
Imquest Biosciences, Inc.'s most recent federal contract award is Niddk - HIV cytoprotection assays 16 compounds (75N94022P00756), from National Institute of Child Health and Human Development (NIH), on September 1, 2022.
On GovTribe
See Imquest Biosciences, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors